Yves Millet, PhD

Director, Biology
Blueprint Medicines Corporation, United States

Disclosure information not submitted.

Presentation(s):

• Discovery of potent, selective and insurmountable MRGPRX2 antagonists for mast cell-driven disorders

  Friday, April 17, 2026
  1:15 PM - 1:30 PM US ET